A Clinical Study Comparing the Bioavailability of HRS-2189 Tablets

Phase 1 Not yet recruiting 28 enrolled Shandong Suncadia Medicine Co., Ltd.

RandomizedCrossoverOpen-labelTreatment

Summary

This study is a single-center, single-dose, randomized, open-label, two-period, crossover phase I clinical trial, comparing the bioavailability and safety of the new and old processes of HRS-2189 tablets in healthy subjects.

Timeline

Start: 2026-06
Primary completion: 2026-07
Completion: 2026-07

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	HRS-2189	Unknown	—	Oral

A Clinical Study Comparing the Bioavailability of HRS-2189 Tablets

Summary

Timeline

Drugs

Indications